Elevated plasminogen activator inhibitor levels in cyclosporin-treated renal allograft recipients

Atherosclerosis and thrombosis, two major causes of morbidity and mortality in renal transplant recipients, share the same clinical risk factors including decreased fibrinolysis and lipid disturbances. In a crosssectional study we have determined parameters of fibrinolysis in control subjects (n=23)...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Nephrology, dialysis, transplantation dialysis, transplantation, 1996-02, Vol.11 (2), p.347-351
Hauptverfasser:	Verpooten, G. A., Cools, F. J., van der Planken, M. G., Bedert, L. C., Claes, R., van Gaal, L. F., de Broe, M. E.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Biological and medical sciences cholesterol cyclosporin Cyclosporine - therapeutic use Female Fibrinolysis Graft Rejection - blood Graft Rejection - prevention & control Humans Immunomodulators Immunosuppressive Agents - therapeutic use Kidney Transplantation lipids Male Medical sciences Middle Aged Pharmacology. Drug treatments plasminogen activator inhibitor Plasminogen Inactivators - analysis renal allograft recipients Risk Factors Transplantation, Homologous
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!